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It has been hypothesized that accelerated growth during fetal life
or an enhanced oestrogenic environment in utero increases subse-
quent breast cancer risk (Trichopoulos, 1990). This hypothesis is
supported by limited indirect epidemiological evidence, including
studies showing that high birth weight and being a dizygotic twin,
both of which are associated with elevated pregnancy oestrogen
levels (Gerhard et al, 1987; Johnson et al, 1994), increase the risk
of developing breast cancer (Braun et al, 1995; Cerhan et al, 2000;
Michels et al, 1996; Sanderson et al, 1996). Animal studies show
that maternal exposure to oestradiol during pregnancy or a high fat
diet that elevates pregnancy oestradiol levels, increase carcino-
gen-induced mammary tumorigenesis among female offspring
(Hilakivi-Clarke et al, 1997). 
Relatively little is known about growth during childhood and
breast cancer. Tall or obese women are at an increased risk of
developing postmenopausal breast cancer (Cold et al, 1996; Vatten
and Kvinnsland, 1990; Yong et al, 1989; Ziegler, 1997). Thin
women are more likely than obese women to develop pre-
menopausal breast cancer (Cleary and Maihle, 1997; Huang et al,
1997; Potischman et al, 1996; Trentham-Dietz et al, 1997). Three
recent studies suggest that high childhood or adolescent body mass
index may protect against breast cancer risk (Berkey et al, 1999;
Le Marchand et al, 1988; Magnusson et al, 1998). Many investiga-
tors, however, believe the opposite and propose that childhood
obesity increases the risk (Colditz and Frazier, 1995; deWaard and
Trichopoulos, 1988; Hunter and Willett, 1996). This belief is
based on the association between childhood obesity and early
onset of puberty (Frisch and McArthur, 1974), since early puberty
is consistently related to increased risk of breast cancer (Hulka and
Stark, 1995). 
We have studied a cohort of 3447 Finnish women whose size at
birth and childhood growth were recorded, to examine whether
height and body mass index during childhood affected breast
cancer risk. We also examined whether childhood growth
modified the effects of birth size on risk. 
METHODS 
The study cohort comprised women who were born at the Helsinki
University Central Hospital during 1924–1933, who went to
school in the city of Helsinki, and were still residents in Finland as
of 1971. The 11-year birth period chosen gives a cohort of women
old enough to have experienced pre-and post-menopausal breast
cancer. Details of the birth records kept by the Helsinki University
Central Hospital have been described previously (Forsen et al,
1997). School health records for all children in Helsinki are stored
in the city archive. Beginning in 1971, all residents of Finland
have been assigned a unique personal identification number. From
the birth and school health records and identification numbers, we
identified 3688 women for use in our study (Forsen et al, 1999). Of
these women, 241 subsequently emigrated and the date of emigra-
tion was not always recorded. We therefore excluded them from
the study to leave 3447 women. 
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Recorded data on the newborn babies included birthweight,
length, head circumference and placental weight. Data on their
mothers included age, parity, height and date of the last menstrual
period, together with body weight, measured on admission in
labour. The school records included an average of 10 (± SD 4)
measurements of height and weight between the ages of 6 and 16
years, recorded during periodic medical examinations. Age at
menarche was not recorded. Further, no information was available
of the factors after menarche that are known to be related to breast
cancer risk, i.e., age at menopause, adult body weight, parity, or
age at first pregnancy. 
By using the personal identification number, we identified all
hospital admissions and deaths among the women during
1971–1995. All hospital admissions in Finland are recorded in the
national hospital discharge register. All deaths are recorded in 
the national mortality register. Causes of hospital admissions or
death were recorded according to ICD-8 (international classifica-
tion of diseases, 8th revision) until 1986; thereafter ICD-9 was
used until 1995. The first three digits from the cause of admission
or death were used to identify breast cancer cases in the cohort
(174 in ICD-8 and ICD-9). 
Statistical methods 
We examined the trends in hazard ratios with maternal, neonatal
and childhood measurements. Tests for trend were based on Cox’s
proportional hazards model. Each measurement of height, weight
and body mass index for each girl was converted to a Z score
(Royston, 1991). We then interpolated between successive Z
scores with a piecewise linear function and so obtained a Z score at
each birthday from age 7 to 15 years. The Z scores were back
transformed to obtain the corresponding height, weight and body
mass index at these ages, as previously described (Forsen et al,
1999). Growth velocity was measured as the change in Z scores
between ages 7 and 15 years. 
RESULTS 
Maternal, neonatal and childhood characteristics of the 3447
women are shown in Table 1. We found that 177 of these women
were admitted to hospital with breast cancer, of whom 49 died
from the disease. The annual death rate from breast cancer at ages
45–64 years was 6.1 per 10 000. In 1971, when the first breast
cancer cases were ascertained, the women’s ages ranged from 38
to 47 years. Although most women would have been pre-
menopausal at that time, 135 (76%) of the 177 women who devel-
oped breast cancer during the follow-up, were aged 50 years or
more at the time of diagnosis and were therefore likely to have
been post-menopausal. In the analyses which follow we found no
differences in the association with breast cancer first diagnosed
below and over the age of 50 years. 
Size at birth 
Table 2 shows hazard ratios for breast cancer according to size at
birth. The ratios tended to rise with increasing birthweight,
Table 1 Maternal, neonatal and childhood characteristics of 3447 women born at Helsinki University Central
Hospital during 1924–33 
Mean (SD) Range No. of  
missing values
Maternal 
Height (m) 1.58 (0.06) 1.04–1.86 245 
Weight in late pregnancy (kg) 66.8 (8.7) 45–134 261 
Body mass index in late pregnancy (kg/m2) 26.7 (3.1) 19.4–51.1 285 
Age (years) 27.7 (5.8) 15–48 9 
Primiparous (%) 42.0 3 
Neonate 
Birthweight (g) 3315 (493) 1470–5600 0 
Head circumference (cm) 34.3 (1.4) 28.0–39.0 10 
Birth length (cm) 49.7 (2.0) 38.0–59.0 12 
Ponderal index (kg/m3) 26.9 (2.4) 15.6–50.0 12 
Placental weight (g) 628 (125) 200–1290 7 
Length of gestation (days) 276 (15) 197–307 179 
% born before 37 weeks gestation 10.1 179 
Child 
Height (m) at age 7 years 1.19 (0.05) 0.98–1.37 0 
at age 11 years 1.39 (0.06) 1.13–1.61 0 
at age 15 years 1.58 (0.06) 1.29–1.81 0 
Weight (kg) at age 7 years 21.7 (2.9) 14.1–37.9 0 
at age 11 years 32.1 (5.1) 18.2–64.5 0 
at age 15 years 49.7 (7.7) 26.2–92.9 0 
Body mass index (kg/m2) at age 7 years 15.3 (1.3) 11.7–24.1 0 
at age 11 years 16.5 (1.7) 12.2–31.2 0 
at age 15 years 19.8 (2.5) 12.3–41.2 0 
No. of people in house 4.5 (1.5) 2–14 570 
No. of rooms in house 1.7 (0.8) 1–7 536 
Crowding (no. of people/no. of rooms)* 2.8 (1.6) 0.6–11 576 
*Log transformed.1682 L Hilakivi-Clarke et al 
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although this was not statistically significant. The trend with birth
length was similar, though also not significant. Hazard ratios were
not related to placental weight nor to the length of gestation. The
trends in Table 2 were little changed by adjusting for gestation. 
Growth in childhood 
Figure 1, based on the Z scores, shows that at each age from 7 to
15 years the women who developed breast cancer were, on
average, taller than the other women (P < 0.05 at every age). At 7
years, for example, their height was 0.8 cm above the average,
while at 15 years it was 1.3 cm above. In contrast, women who
developed breast cancer were thinner than the other women at all
ages from 7 to 15 years (P < 0.05 at each age). Their body mass
index at 7 years was 0.3 kg/m2 below the average and at 15 years it
was 0.4 kg/m2 below the average. The changes in Z-score for
height, weight and body mass index from 7 to 15 years were not
statistically significantly different from those of the other women. 
Table 3 shows hazard ratios for breast cancer according to
height and body mass index at 7 and 15 years. The trends for
increased breast cancer risk with increasing height and falling
body mass index were both statistically significant. Body mass
index at 7 years was not strongly correlated with birthweight
(correlation coefficient = 0.15). In a simultaneous analysis, the
hazard ratio for breast cancer was 1.21 (95% CI 1.06–1.38, P =
0.004) for every kg/m2 decrease in body mass index at 7 years and
1.27 (95% CI 0.97–1.78, P = 0.08) for every kilogram increase in
birthweight. There was no interaction between birthweight and
body mass index in their effect on breast cancer risk. 
Maternal characteristics 
As expected, taller mothers tended to have taller daughters, the
correlation coefficient between mothers’ and daughters’ height at
7 being 0.36; and mothers with higher body mass indices had
daughters with higher body mass indices, correlation coefficient
being 0.23 at age 7 years. However, mothers’ heights, weights and
body mass indices during pregnancy were unrelated to the occur-
rence of breast cancer in their daughters. Similarly, the mothers’ ages
and parities were not related to their daughters’ breast cancer risk. 
DISCUSSION 
The present study investigated associations between early growth
and breast cancer risk in a cohort of 3447 Finnish women, born in
Helsinki, most of whom developed the disease after the age of 50
years, that is post-menopausally. We found that high birth weight
and long body length at birth were associated with increased risk
of the disease, although the association did not reach statistical
significance. These borderline associations are similar to those
found in a cohort of Swedish women born in Uppsala (Ekbom
et al, 1992). 
In addition to size at birth, we were able to examine how growth
between 7 and 15 years modified the risk of breast cancer. We
found that women who developed the disease had above average
height through childhood but were relatively thin, with a below
average body mass index. We did not have information on adult
body mass index, and it is possible that these associations with
childhood height and body mass are mediated through effects 
of adult body mass on breast cancer risk. However, it is clear 
that childhood body mass did not mediate the effects of high 
Table 2 Hazard ratios for breast cancer according to size at birth 
Variable No. of cases No. of women Hazard ratio (95% CI) 
Birthweight (g) 
≤ 2500 6 191 1.0 
3000 31 708 1.4 (0.6–3.4) 
3500 84 1420 1.9 (0.8–4.3) 
4000 41 880 1.5 (0.6–3.5) 
>4000 15 248 1.9 (0.7–5.0) 
Hazard ratio per kg = 1.22 (0.90 to 1.65) P = 0.2 
Birth length (cms) 
<48 27 726 1.0 
49 30 595 1.4 (0.8–2.3) 
50 65 1077 1.6 (1.0–2.5) 
51 32 588 1.5 (0.9–2.5) 
>51 23 449 1.4 (0.8–2.4) 
Hazard ratio per cm = 1.06 (0.98 to 1.15) P = 0.13 
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Figure 1 Height, weight and body mass index during childhood, expressed
as standard deviation (Z) scores, in women who later developed breast
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birthweight, since they had independent and opposite effects on
breast cancer risk. 
Earlier studies have shown that, after the menopause, tall
women are more prone to develop breast cancer than shorter
women (Cold et al, 1996; Vatten and Kvinnsland, 1990; Ziegler,
1997). Our data show that the association of tallness with breast
cancer may reflect a greater height from birth onwards. Increased
breast cancer risk was associated with increased length at birth
followed by above average height at every age from 7 to 15 years.
Previously, the Nurses’ Health Study (Berkey et al, 1999) found an
association between high peak height growth velocity, the most
growth attained during any single year of adolescence, and an
increased risk of breast cancer. The observation, however, was
based on estimates of growth velocity derived from recalled body
fatness at 10 years, menarcheal age and adult height. The results of
our study, which are based on actual measurements of height
during childhood, show that the velocity of height growth does not
predict breast cancer risk. 
Girls who are tall during childhood tend to have an earlier
menarche than short girls (Ellison, 1981; Marshall and De
Limongi, 1976) and our observations that tall girls exhibit
increased breast cancer risk may partly explain the association
between breast cancer and early menarche (Hulka and Stark,
1995). Greater height in childhood is associated with higher
plasma concentrations of insulin-like growth factor-1 (IGF-1)
(Juul and Skakkebaek, 1997; Nilsson et al, 1994), and this growth
factor plays an important role in determining onset of puberty
(Hiney et al, 1996; Juul et al, 1995). Furthermore, high plasma
IGF-1 concentrations in pre-menopausal women are associated
with increased breast cancer risk (Hankinson et al, 1998). IGF-1 is
therefore a possible link between childhood height, age at
menarche and breast cancer. 
Puberty occurs when a girl reaches a critical weight/body mass,
and overweight girls tend to experience menarche earlier than girls
with normal body weight (Frisch and McArthur, 1974). It might be
expected that overweight girls would have increased breast cancer
risk. However, neither earlier prospective data (Le Marchand et al,
1988), nor retrospective data (Berkey et al, 1999; Magnusson et al,
1998) support this. Two retrospective case-control studies were
based on information about childhood body mass as it was recalled
during adult life before or after breast cancer diagnosis (Berkey
et al, 1999; Magnusson et al, 1998). It is important to note that few
girls in Finland were obese 60 years ago, when women in our
cohort were children. The highest BMI category at age 15 was
> 21.5 kg/m2, which according to present standards represents
normal body size. We cannot therefore conclude that childhood
obesity, as defined in clinical practice today, protects against
breast cancer. 
Recent animal studies may provide clues to the biological
mechanisms that link high childhood body mass index to a low
risk of breast cancer. In animals exposed to oestrogens in early
life, the mammary glands may differentiate early and are less
susceptible to developing tumours upon exposure to carcinogens
(Grubbs et al, 1985; Nagasawa et al, 1974). In humans, body mass
index is an indicator of oestrogenicity, especially before puberty
when adipose tissue is the major site of oestrogen release. Perhaps
being overweight in childhood induces early breast differentiation
and eliminates some undifferentiated mammary epithelial cells as
targets for malignant transformation. Another possibility is that
the oestrogenic effects of high childhood body mass increase the
Table 3 Hazard ratios for breast cancer according to body size at 7 and 15 years 
Variable No. of cases No. of women Hazard ratio 
(95% CI) 
Height at age 7 (cm) 
≤ 114.5 22 641 1.0 
117.5 32 703 1.3 (0.8–2.3) 
120 39 694 1.7 (1.0–2.8) 
123 41 722 1.7 (1.0–2.9) 
>123 43 687 1.9 (1.1–3.1) 
P for trend = 0.01 
Height at age 15 (cm) 
≤ 153 23 657 1.0 
157 34 750 1.3 (0.8–2.2) 
160 33 720 1.3 (0.8–2.2) 
163 38 604 1.8 (1.1–3.1) 
>163 49 716 1.9 (1.2–3.2) 
P for trend = 0.005 
BMI at age 7 (kg/m2) 
≤ 14.3 46 701 1.9 (1.2–3.1) 
14.9 34 682 1.4 (0.8–2.4) 
15.5 45 715 1.8 (1.1–2.9) 
16.2 27 642 1.2 (0.7–2.1) 
>16.2 25 707 1.0 
P for trend = 0.009 
BMI at age 15 (kg/m2)
≤ 18 49 769 1.7 (1.0–2.7) 
19 33 596 1.4 (0.9–2.4) 
20 38 649 1.5 (0.9–2.4) 
21.5 29 724 1.0 (0.6–1.7) 
>21.5 28 709 1.0 
P for trend = 0.03 1684 L Hilakivi-Clarke et al 
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expression of tumour suppressor genes, such as BRCA1 (Hilakivi-
Clarke 2000). This gene is known to be over-expressed during
puberty (Marquis et al, 1995). It is induced by oestrogens (Gudas 
et al, 1995; Spillman and Bowcock, 1996) and its activity is associ-
ated with increased breast differentiation (Rajan et al, 1996), main-
tenance of the genomic integrity and DNA repair (Gowen, 1998). 
In conclusion, we have found that women who developed
breast cancer were tall and thin at all ages from 7 to 15 years. We
speculate that these associations reflect the effects of high plasma
concentrations of insulin-like growth factors, and a protective
effect of high body mass through early breast differentiation. 
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